应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BCDA BioCardia
休市中 07-05 16:00:00 EDT
2.97
-0.02
-0.67%
盘后
2.97
+0.00
0.00%
19:32 EDT
最高
3.10
最低
2.80
成交量
3.65万
今开
3.06
昨收
2.99
日振幅
10.03%
总市值
542.18万
流通市值
358.89万
总股本
182.55万
成交额
10.76万
换手率
3.02%
流通股本
120.84万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Biocardia, Inc.盘中异动 下午盘股价大跌6.35%
自选股智能写手 · 07-06 01:14
Biocardia, Inc.盘中异动 下午盘股价大跌6.35%
BUZZ-BioCardia 因获得美国心脏设备专利而大涨
Reuters · 06-07
BUZZ-BioCardia 因获得美国心脏设备专利而大涨
Biocardia, Inc.盘中异动 快速拉升5.80%报0.346美元
自选股智能写手 · 05-24
Biocardia, Inc.盘中异动 快速拉升5.80%报0.346美元
Biocardia, Inc.盘中异动 股价大跌7.02%
自选股智能写手 · 05-22
Biocardia, Inc.盘中异动 股价大跌7.02%
BioCardia Inc 预计每股亏损11美分 - 财报前瞻
Reuters · 03-26
BioCardia Inc 预计每股亏损11美分 - 财报前瞻
加载更多
公司概况
公司名称:
BioCardia
所属市场:
NASDAQ
上市日期:
--
主营业务:
Biocardia, Inc.于1994年1月12日在特拉华州注册成立。该公司是一家临床阶段的再生医学公司,为具有大量未满足的医疗需求的心血管疾病开发新的治疗药物。他们的主要治疗候选药物是研究性CardiAMP细胞治疗系统,该系统提供自体骨髓衍生细胞疗法(使用患者自身细胞)治疗两种临床适应症:心脏病发作和慢性心肌缺血后发生的心力衰竭。
发行价格:
--
{"stockData":{"symbol":"BCDA","market":"US","secType":"STK","nameCN":"BioCardia","latestPrice":2.97,"timestamp":1720209600000,"preClose":2.99,"halted":0,"volume":36466,"hourTrading":{"tag":"盘后","latestPrice":2.97,"preClose":2.97,"latestTime":"19:32 EDT","volume":93,"amount":273.42,"timestamp":1720222363306},"delay":0,"floatShares":1208400,"shares":1825506,"eps":-6.9603,"marketStatus":"休市中","marketStatusCode":7,"change":-0.02,"latestTime":"07-05 16:00:00 EDT","open":3.06,"high":3.1,"low":2.8,"amount":107553.7393432,"amplitude":0.100334,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.9603,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1720425600000},"adr":0,"adjPreClose":2.99,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":2.97,"preClose":2.97,"latestTime":"19:32 EDT","volume":93,"amount":273.42,"timestamp":1720222363306},"volumeRatio":1.2605518488379601,"impliedVol":0.8044,"impliedVolPercentile":0.3391},"requestUrl":"/m/hq/s/BCDA","defaultTab":"news","newsList":[{"id":"2449290244","title":"Biocardia, Inc.盘中异动 下午盘股价大跌6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449290244","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449290244?lang=zh_cn&edition=full","pubTime":"2024-07-06 01:14","pubTimestamp":1720199695,"startTime":"0","endTime":"0","summary":"北京时间2024年07月06日01时14分,Biocardia, Inc.股票出现波动,股价快速跳水6.35%。Biocardia, Inc.股票所在的生物技术行业中,整体涨幅为1.25%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。消息层面,截至01时14分,《BioCardia董事增持500股普通股股份,价值约1,513美元》资讯为影响Biocardia, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706011455941f47b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706011455941f47b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2441063172","title":"BUZZ-BioCardia 因获得美国心脏设备专利而大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2441063172","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441063172?lang=zh_cn&edition=full","pubTime":"2024-06-07 20:57","pubTimestamp":1717765031,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 6月7日 - ** 细胞疗法开发商 BioCardia 的股价盘前上涨 17.3% 至 5.12 美元 ** 公司称已获得其心脏设备的美国专利,该专利将于2036年到期 ** 该专利与桡动脉输送系统有关,通过该系统可将心脏导管穿过病人手腕上的血管,对心脏进行治疗。 ** 该公司称,其输送系统旨在通过在输送过程中与心脏组织稳定、安全地接触,防止治疗药物泄漏** 截至上次收盘,该公司股价年累计下跌 56.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA","BUZZ","BK4139"],"gpt_icon":0},{"id":"2437964052","title":"Biocardia, Inc.盘中异动 快速拉升5.80%报0.346美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437964052","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437964052?lang=zh_cn&edition=full","pubTime":"2024-05-24 23:47","pubTimestamp":1716565674,"startTime":"0","endTime":"0","summary":"北京时间2024年05月24日23时47分,Biocardia, Inc.股票出现异动,股价急速拉升5.80%。截至发稿,该股报0.346美元/股,成交量14.9712万股,换手率0.55%,振幅7.03%。Biocardia, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524234755aef198cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240524234755aef198cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCDA","BK4139"],"gpt_icon":0},{"id":"2437951392","title":"Biocardia, Inc.盘中异动 股价大跌7.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437951392","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437951392?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:31","pubTimestamp":1716384677,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时31分,Biocardia, Inc.股票出现波动,股价急速跳水7.02%。Biocardia, Inc.股票所在的生物技术行业中,整体跌幅为0.40%。其相关个股中,Sab Biotherapeutics Inc C/Wts 22/10/2026 、Rezolute, Inc.、Mustang Bio, Inc.涨幅较大,Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Coeptis Therapeutics Holdings, Inc.较为活跃,换手率分别为183.44%、88.21%、32.28%,振幅较大的相关个股有Nutriband Inc C/Wts 、Eupraxia Pharmaceuticals Inc.、Avalo Therapeutics, Inc.,振幅分别为12.90%、8.33%、7.60%。Biocardia, Inc.公司简介:BioCardia Inc 是一家临床阶段公司,开发细胞和细胞衍生疗法,用于治疗未满足医疗需求的心血管和肺部疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052221311895503dfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052221311895503dfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BCDA"],"gpt_icon":0},{"id":"2422575444","title":"BioCardia Inc 预计每股亏损11美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2422575444","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422575444?lang=zh_cn&edition=full","pubTime":"2024-03-26 04:26","pubTimestamp":1711398371,"startTime":"0","endTime":"0","summary":" * BioCardia Inc 将于3月27日公布截至2023年12月31日的季度财报,预计该公司的季度收入将出现下降。* LSEG 分析师对 BioCardia Inc 的平均预期是每股亏损 11 美分。* 华尔街对 BioCardia Inc 的 12 个月目标价中位数为 4.00 美元,高于上一次 0.41 美元的收盘价。3月25日 - 本摘要于北京时间 3 月 25 日 20:26 机器生成。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biocardia.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.325},{"period":"3month","weight":-0.4864},{"period":"6month","weight":-0.6951},{"period":"1year","weight":-0.9256},{"period":"ytd","weight":-0.7019}],"compareEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0698},{"period":"6month","weight":0.1853},{"period":"1year","weight":0.2615},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Biocardia, Inc.于1994年1月12日在特拉华州注册成立。该公司是一家临床阶段的再生医学公司,为具有大量未满足的医疗需求的心血管疾病开发新的治疗药物。他们的主要治疗候选药物是研究性CardiAMP细胞治疗系统,该系统提供自体骨髓衍生细胞疗法(使用患者自身细胞)治疗两种临床适应症:心脏病发作和慢性心肌缺血后发生的心力衰竭。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.06938},{"month":2,"riseRate":0.5,"avgChangeRate":-0.000116},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.063445},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.020094},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.051537},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.041157},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.034599},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.126545},{"month":9,"riseRate":0.333333,"avgChangeRate":0.0658},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.037787},{"month":11,"riseRate":0.5,"avgChangeRate":0.054404},{"month":12,"riseRate":0.5,"avgChangeRate":0.01405}],"exchange":"NASDAQ","name":"BioCardia","nameEN":"BioCardia"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioCardia(BCDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioCardia(BCDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioCardia,BCDA,BioCardia股票,BioCardia股票老虎,BioCardia股票老虎国际,BioCardia行情,BioCardia股票行情,BioCardia股价,BioCardia股市,BioCardia股票价格,BioCardia股票交易,BioCardia股票购买,BioCardia股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioCardia(BCDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioCardia(BCDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}